Important notification
06.12.2020 To the attention of interested persons Submission and receipt of messages by e-mail (e-mail@anm.ro) In line with the NAMMDR […]
Press release
06.12.2021 To the attention of interested persons EMA recommends approval for use of RoActemra in adults with severe COVID-19 download […]
Press release
03.12.2021 To the attention of interested persons Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 29 November – 2 […]
Press release
25.11.2021 To the attention of interested persons Comirnaty COVID-19 vaccine: EMA recommends approval for children aged 5 to 11 download […]
Press release
23.11.2021 To the attention of interested persons EMA receives application for marketing authorisation for Lagevrio (molnupiravir) for treating patients with […]
Press release
22.11.2021 To the attention of interested persons EMA evaluating data on booster dose of COVID-19 Vaccine Janssen download document …
Press release
19.11.2021 To the attention of interested persons EMA starts review of Paxlovid for treating patients with COVID-19 download document …
Press release
18.11.2021 To the attention of interested persons EMA receives application for marketing authorisation for Xevudy (sotrovimab) for treating patients with […]
Press release
17.11.2021 To the attention of interested persons EMA receives application for conditional marketing authorisation of Novavax’s COVID-19 vaccine, Nuvaxovid download […]
Important notification
15.11.2021 To the attention of Romanian manufacturers of medical devices UDI/Device registration – in EUDAMED The new EU regulations of […]